Your session is about to expire
← Back to Search
Pharmacist-Driven Intervention for Medication Adherence
N/A
Waitlist Available
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 35 months
Awards & highlights
Study Summary
This trial will test whether a pharmacist-driven intervention can improve adherence to specialty medications.
Eligible Conditions
- Medication Nonadherence
- Medication Adherence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 35 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~35 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Median Proportion of Days Covered (PDC) at 8-months Post-enrollment
Secondary outcome measures
Median Proportion of Days Covered (PDC) at 12-months Post-enrollment
Median Proportion of Days Covered (PDC) at 6-months Post-enrollment
Reasons for Nonadherence in the Intervention Arm
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacist-Driven InterventionExperimental Treatment1 Intervention
The study group will receive a patient-tailored, pharmacist-driven intervention(s) to overcome patient-specific barriers to adherence. Each patient in the study group will be intervened upon using a protocol that is based on their reason for non-adherence.
Group II: Standard of CareActive Control1 Intervention
The usual care group will receive the standard of care provided to all patients that utilize Vanderbilt Specialty Pharmacy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pharmacist-Driven Intervention
2019
N/A
~440
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
671,754 Total Patients Enrolled
Jacob Jolly, Pharm. D.Study ChairVanderbilt University Medical Center
Autumn D Zuckerman, Pharm.D.Study DirectorVanderbilt University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Pharmacist-Driven Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current opportunities for potential participants to join this experiment?
"Based on the information hosted by clinicaltrials.gov, this medical trial is not currently engaging in participant recruitment. It was first posted on May 10th 2019 and last updated January 10 2022; however, there are 85 other studies actively seeking participants at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger